Evidence map›Paper›PMID 31873910›Full record

ArticleJournal of endocrinological investigation2020

Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

F Saponaro, F Cetani, L Mazoni, M Apicella, M Di Giulio, F Carlucci, M Scalese, E Pardi, S Borsari, J P Bilezikian and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

F SaponaroDepartment of Pathology, University of Pisa, Pisa, Italy. federica.saponaro@unipi.it.ORCID http://orcid.org/0000-0002-0277-1648
F CetaniEndocrinology Unit, University of Pisa, Pisa, Italy.
L MazoniEndocrinology Unit, University of Pisa, Pisa, Italy.
M ApicellaEndocrinology Unit, University of Pisa, Pisa, Italy.
M Di GiulioEndocrinology Unit, University of Pisa, Pisa, Italy.
F CarlucciEndocrinology Unit, University of Pisa, Pisa, Italy.
M ScaleseInstitute of Clinical Physiology, National Council of Research, Pisa, Italy.
E PardiEndocrinology Unit, University of Pisa, Pisa, Italy.
S BorsariEndocrinology Unit, University of Pisa, Pisa, Italy.
J P BilezikianMetabolic Bone Diseases Unit, Division of Endocrinology, Department of Medicine, College of Physician and Surgeons, Columbia University, New York, NY, USA.
C MarcocciEndocrinology Unit, University of Pisa, Pisa, Italy.
University of Pisa · ITColumbia University · USIstituto di Fisiologia Clinica · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe latest guidelines of the 4th International Workshop on Asymptomatic Primary Hyperparathyroidism (aPHPT) reintroduced hypercalciuria (i.e. urinary calcium > 400 mg/day) as criterion for surgery. However, the value of hypercalciuria as a predictor of nephrolithiasis and the correct cut-off values still need to be confirmed.

objectiveTo evaluate the prevalence of silent kidney stones in a large series of patients with aPHPT and the sensibility, specificity and predictive value of different cut-off values of hypercalciuria in identifying patients with nephrolithiasis.

designOne hundred seventy-six consecutive patients with aPHPT were evaluated at our Institution by serum and urinary parameters and kidney ultrasound.

resultsSilent nephrolithiasis was found in 38 (21.6%) patients. In the univariate and multivariate model, hypercalciuria was a predictor of nephrolithiasis using the criterion of 400 mg/24 h [(OR 2.30, (1.11-4.82) P = 0.025], 4 mg/kg/bw [OR 2.65, (1.14-6.25) P = 0.023], gender criterion [OR 2.79, (1.15-6.79) P = 0.023] and the cut-off value derived from the ROC analysis [(> 231 mg/24 h) OR 5.02 (1.68-14.97) P = 0.004]. Despite these several predictive criteria, however, hypercalciuria had a low positive predictive value (PPV), ranging from 27.4 to 32.7%.

conclusionsHypercalciuria is a predictor of nephrolithiasis, but its PPV is low.

Indexed as

AdultAgedFemaleHumansHypercalciuriaHyperparathyroidism, PrimaryKidney CalculiMaleMiddle AgedNephrolithiasisPredictive Value of TestsRisk FactorsUltrasonographyNephrolithiasisPrimary hyperparathyroidismStone risk

Identifiers

PMID31873910
OpenAlexW2997040982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.